Diabetes, diabetes treatment and breast cancer prognosis

Juhua Luo, Beth Virnig, Michael Hendryx, Sijin Wen, Rowan Chelebowski, Chu Chen, Thomas E. Rohan, Lesley Tinker, Jean Wactawski-Wende, Lawrence Lessin, Karen Margolis

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The objectives of this study are to assess the impact of pre-existing diabetes and diabetes treatment on breast cancer prognosis. 8,108 women with centrally confirmed invasive breast cancer in the Women’s Health Initiative diagnosed between 1998 and 2013 were followed through the date of death or September 20, 2013. Information on diabetes and diabetes therapy were obtained via self-report and face-to-face review of current medication containers, respectively. Cox proportional hazard regression was used to estimate adjusted relative hazard ratios for overall mortality. The proportional subdistribution hazard model was used to estimate hazard ratios for breast cancer-specific mortality. Compared with women without diabetes, women with diabetes had significantly increased risk of overall mortality (HR 1.26 95 % CI 1.06–1.48), especially among those who took insulin or had longer duration of diabetes. However, diabetes was not associated with increased risk of breast cancer-specific mortality, regardless of type of treatment and duration of diabetes, despite the significant association of diabetes with unfavorable tumor characteristics. Our large prospective cohort study provides additional evidence that pre-existing diabetes increases risk of total mortality among women with breast cancer. The increased total mortality associated with diabetes was mainly driven by increased risk of dying from diseases other than breast cancer. Thus, the continuum of care for breast cancer patients with diabetes should include careful attention to CVD risk factors and other non-cancer conditions.

Original languageEnglish (US)
Pages (from-to)153-162
Number of pages10
JournalBreast Cancer Research and Treatment
Volume148
Issue number1
DOIs
StatePublished - Oct 14 2014

Fingerprint

Breast Neoplasms
Mortality
Therapeutics
Continuity of Patient Care
Women's Health
Proportional Hazards Models
Self Report
Cohort Studies
Prospective Studies
Insulin
Neoplasms

Keywords

  • Breast cancer
  • Diabetes
  • Diabetes treatment
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Luo, J., Virnig, B., Hendryx, M., Wen, S., Chelebowski, R., Chen, C., ... Margolis, K. (2014). Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Research and Treatment, 148(1), 153-162. https://doi.org/10.1007/s10549-014-3146-9

Diabetes, diabetes treatment and breast cancer prognosis. / Luo, Juhua; Virnig, Beth; Hendryx, Michael; Wen, Sijin; Chelebowski, Rowan; Chen, Chu; Rohan, Thomas E.; Tinker, Lesley; Wactawski-Wende, Jean; Lessin, Lawrence; Margolis, Karen.

In: Breast Cancer Research and Treatment, Vol. 148, No. 1, 14.10.2014, p. 153-162.

Research output: Contribution to journalArticle

Luo, J, Virnig, B, Hendryx, M, Wen, S, Chelebowski, R, Chen, C, Rohan, TE, Tinker, L, Wactawski-Wende, J, Lessin, L & Margolis, K 2014, 'Diabetes, diabetes treatment and breast cancer prognosis', Breast Cancer Research and Treatment, vol. 148, no. 1, pp. 153-162. https://doi.org/10.1007/s10549-014-3146-9
Luo J, Virnig B, Hendryx M, Wen S, Chelebowski R, Chen C et al. Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Research and Treatment. 2014 Oct 14;148(1):153-162. https://doi.org/10.1007/s10549-014-3146-9
Luo, Juhua ; Virnig, Beth ; Hendryx, Michael ; Wen, Sijin ; Chelebowski, Rowan ; Chen, Chu ; Rohan, Thomas E. ; Tinker, Lesley ; Wactawski-Wende, Jean ; Lessin, Lawrence ; Margolis, Karen. / Diabetes, diabetes treatment and breast cancer prognosis. In: Breast Cancer Research and Treatment. 2014 ; Vol. 148, No. 1. pp. 153-162.
@article{6ae2e777f26146fbae330fa245f7af5e,
title = "Diabetes, diabetes treatment and breast cancer prognosis",
abstract = "The objectives of this study are to assess the impact of pre-existing diabetes and diabetes treatment on breast cancer prognosis. 8,108 women with centrally confirmed invasive breast cancer in the Women’s Health Initiative diagnosed between 1998 and 2013 were followed through the date of death or September 20, 2013. Information on diabetes and diabetes therapy were obtained via self-report and face-to-face review of current medication containers, respectively. Cox proportional hazard regression was used to estimate adjusted relative hazard ratios for overall mortality. The proportional subdistribution hazard model was used to estimate hazard ratios for breast cancer-specific mortality. Compared with women without diabetes, women with diabetes had significantly increased risk of overall mortality (HR 1.26 95 {\%} CI 1.06–1.48), especially among those who took insulin or had longer duration of diabetes. However, diabetes was not associated with increased risk of breast cancer-specific mortality, regardless of type of treatment and duration of diabetes, despite the significant association of diabetes with unfavorable tumor characteristics. Our large prospective cohort study provides additional evidence that pre-existing diabetes increases risk of total mortality among women with breast cancer. The increased total mortality associated with diabetes was mainly driven by increased risk of dying from diseases other than breast cancer. Thus, the continuum of care for breast cancer patients with diabetes should include careful attention to CVD risk factors and other non-cancer conditions.",
keywords = "Breast cancer, Diabetes, Diabetes treatment, Prognosis",
author = "Juhua Luo and Beth Virnig and Michael Hendryx and Sijin Wen and Rowan Chelebowski and Chu Chen and Rohan, {Thomas E.} and Lesley Tinker and Jean Wactawski-Wende and Lawrence Lessin and Karen Margolis",
year = "2014",
month = "10",
day = "14",
doi = "10.1007/s10549-014-3146-9",
language = "English (US)",
volume = "148",
pages = "153--162",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Diabetes, diabetes treatment and breast cancer prognosis

AU - Luo, Juhua

AU - Virnig, Beth

AU - Hendryx, Michael

AU - Wen, Sijin

AU - Chelebowski, Rowan

AU - Chen, Chu

AU - Rohan, Thomas E.

AU - Tinker, Lesley

AU - Wactawski-Wende, Jean

AU - Lessin, Lawrence

AU - Margolis, Karen

PY - 2014/10/14

Y1 - 2014/10/14

N2 - The objectives of this study are to assess the impact of pre-existing diabetes and diabetes treatment on breast cancer prognosis. 8,108 women with centrally confirmed invasive breast cancer in the Women’s Health Initiative diagnosed between 1998 and 2013 were followed through the date of death or September 20, 2013. Information on diabetes and diabetes therapy were obtained via self-report and face-to-face review of current medication containers, respectively. Cox proportional hazard regression was used to estimate adjusted relative hazard ratios for overall mortality. The proportional subdistribution hazard model was used to estimate hazard ratios for breast cancer-specific mortality. Compared with women without diabetes, women with diabetes had significantly increased risk of overall mortality (HR 1.26 95 % CI 1.06–1.48), especially among those who took insulin or had longer duration of diabetes. However, diabetes was not associated with increased risk of breast cancer-specific mortality, regardless of type of treatment and duration of diabetes, despite the significant association of diabetes with unfavorable tumor characteristics. Our large prospective cohort study provides additional evidence that pre-existing diabetes increases risk of total mortality among women with breast cancer. The increased total mortality associated with diabetes was mainly driven by increased risk of dying from diseases other than breast cancer. Thus, the continuum of care for breast cancer patients with diabetes should include careful attention to CVD risk factors and other non-cancer conditions.

AB - The objectives of this study are to assess the impact of pre-existing diabetes and diabetes treatment on breast cancer prognosis. 8,108 women with centrally confirmed invasive breast cancer in the Women’s Health Initiative diagnosed between 1998 and 2013 were followed through the date of death or September 20, 2013. Information on diabetes and diabetes therapy were obtained via self-report and face-to-face review of current medication containers, respectively. Cox proportional hazard regression was used to estimate adjusted relative hazard ratios for overall mortality. The proportional subdistribution hazard model was used to estimate hazard ratios for breast cancer-specific mortality. Compared with women without diabetes, women with diabetes had significantly increased risk of overall mortality (HR 1.26 95 % CI 1.06–1.48), especially among those who took insulin or had longer duration of diabetes. However, diabetes was not associated with increased risk of breast cancer-specific mortality, regardless of type of treatment and duration of diabetes, despite the significant association of diabetes with unfavorable tumor characteristics. Our large prospective cohort study provides additional evidence that pre-existing diabetes increases risk of total mortality among women with breast cancer. The increased total mortality associated with diabetes was mainly driven by increased risk of dying from diseases other than breast cancer. Thus, the continuum of care for breast cancer patients with diabetes should include careful attention to CVD risk factors and other non-cancer conditions.

KW - Breast cancer

KW - Diabetes

KW - Diabetes treatment

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84921937722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921937722&partnerID=8YFLogxK

U2 - 10.1007/s10549-014-3146-9

DO - 10.1007/s10549-014-3146-9

M3 - Article

C2 - 25261292

AN - SCOPUS:84921937722

VL - 148

SP - 153

EP - 162

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -